Astrocytes in Parkinson Disease

Parkinson's disease (PD) is a neurodegenerative disorder caused by the progressive loss of dopaminergic neurons. Some PD-genes may be associated with astrocyte dysfunction. Discover the latest research on astrocytes in Parkinson's disease here.

January 13, 2022

Effect of Coffee against MPTP-Induced Motor Deficits and Neurodegeneration in Mice Via Regulating Gut Microbiota.

Journal of Agricultural and Food Chemistry
Jiaming LiuYang Zhang
January 12, 2022
Open Access

Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Improves Cognitive Functions in Mice after Controlled Cortical Impact Injury.

International Journal of Molecular Sciences
Suresh B RangasamyKalipada Pahan
January 10, 2022

Inhibition of TRPM2 by AG490 Is Neuroprotective in a Parkinson's Disease Animal Model.

Molecular Neurobiology
Ana Flávia Fernandes FerreiraLuiz Roberto Britto
January 4, 2022

Primary cilia and ciliary signaling pathways in aging and age-related brain disorders.

Neurobiology of Disease
Rong MaGuoku Hu
January 2, 2022

Dietary fats modulate neuroinflammation in mucin 2 knock out mice model of spontaneous colitis.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Tyler J WenzelAndis Klegeris
December 31, 2021

Ca2+ /Calcineurin-mediated release of exosomal miR-23a regulates astrocyte-neuron cross-talk and protects against neuroinflammation and neurodegeneration.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Pallabi Bhattacharyya, Subhas Chandra Biswas
December 25, 2021
Open Access

Ionizing Radiation-Induced Brain Cell Aging and the Potential Underlying Molecular Mechanisms.

Qin-Qi WangFeng-Ru Tang
December 23, 2021
Open Access

Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.

Oxidative Medicine and Cellular Longevity
Xiaoting ZhouXin Fang
December 21, 2021
Open Access

Extracellular Vesicles as Drug Delivery System for Treatment of Neurodegenerative Disorders: Optimization of the Cell Source.

Advanced Nanobiomed Research
Matthew J HaneyElena V Batrakova
December 18, 2021

Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.

Brain : a Journal of Neurology
Semra SmajićMalte Spielmann
December 16, 2021

Cerebral dopamine neurotrophic factor protects and repairs dopamine neurons by novel mechanism.

Molecular Psychiatry
Päivi Lindholm, Mart Saarma
December 11, 2021
Open Access

Astrocytes Exhibit a Protective Role in Neuronal Firing Patterns under Chemically Induced Seizures in Neuron-Astrocyte Co-Cultures.

International Journal of Molecular Sciences
Annika AhtiainenKerstin Lenk
December 10, 2021

Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson's Disease.

Complex Psychiatry
Angela A TranDean L Pountney
December 7, 2021

PET imaging of reactive astrocytes in neurological disorders.

European Journal of Nuclear Medicine and Molecular Imaging
Yu LiuHong Zhang
November 28, 2021
Open Access

The Different Molecular Code in Generation of Dopaminergic Neurons from Astrocytes and Mesenchymal Stem Cells.

International Journal of Molecular Sciences
Nana WangJingzhong Zhang
November 28, 2021
Open Access

Versatile Role of Prokineticins and Prokineticin Receptors in Neuroinflammation.

Roberta Lattanzi, Rossella Miele

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved